Content
78%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
Highly actionable content with concrete tool signatures, gotchas, fallbacks, and example workflows, organized around a clear six-phase pipeline. It is somewhat over-long with API detail inlined and would benefit from splitting reference material into bundle files and adding an explicit validation step before emitting clinical recommendations.
Suggestions
Split the per-tool API reference (signatures, return shapes, parameter notes) into a references/ file and keep SKILL.md as an overview pointing to it, improving progressive disclosure.
Add an explicit validation/safety checkpoint (e.g., confirm evidence level and FDA label before outputting a dosing recommendation) to strengthen workflow_clarity for high-stakes clinical guidance.
Trim redundant tool descriptions that appear in multiple phases (e.g., CPIC_get_drug_info, PharmGKB_get_dosing_guidelines) to a single canonical entry referenced by phase.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Largely lean and action-oriented with no padding about what PGx is, but ~270 lines inline detailed tool signatures and parameter notes that could be trimmed or offloaded, leaving minor over-explanation. | 4 / 5 |
Actionability | Provides concrete tool signatures, required parameter names, return shapes, gotchas, fallback strategies, and copy-ready example workflows covering drug-first, gene-first, and variant-first cases. | 5 / 5 |
Workflow Clarity | A clear six-phase sequence diagram plus explicit fallback strategies and reasoning chains; however it lacks an explicit validate→fix→retry feedback loop for the high-stakes clinical output it produces. | 4 / 5 |
Progressive Disclosure | All API reference material is inlined in SKILL.md with no references/ or other bundle files present; the bulk tool reference could be split out, and structure is section-based but references are not used. | 3 / 5 |
Total | 16 / 20 Passed |